Skip to content

Ultra-high-frequency ECG for Prediction of Left Ventricular Remodeling

Ultra-high-frequency ECG for Prediction of Adverse Left Ventricular Remodeling in Permanent Right Ventricular Pacing

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04908033
Enrollment
368
Registered
2021-06-01
Start date
2021-05-01
Completion date
2025-12-01
Last updated
2025-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyssynchrony, Negative Remodeling, Physiological Pacing, RV Pacing, UHF-ECG

Keywords

myocardial pacing, physiological pacing, negative remodeling, dyssynchrony, ultra-high-frequency ECG

Brief summary

The main goal of the project is to prove that ultra-high-frequency ECG (UHF-ECG) can be used as a diagnostic tool that allows the prediction of patients susceptible to the negative effect of right ventricular myocardial pacing. The prediction will be based on the assessment of electrical dyssynchrony and local depolarization durations of left ventricular depolarization emerging during right ventricular pacing. If proved to be valid in left ventricular negative remodeling prediction, UHF-ECG-derived parameters of ventricular dyssynchrony could be used as markers allowing a lead placement optimization during an implant procedure. This information can help the operator to identify patients with the urgent need for physiological pacing (HB or LBBp) and patients in which a right ventricular myocardial pacing is sufficient and will not lead to the development of the negative left ventricular remodeling.

Interventions

DEVICEpacemaker implantation

pacemaker implantation

Sponsors

St. Anne's University Hospital Brno, Czech Republic
CollaboratorOTHER
Regional Hospital Liberec
CollaboratorOTHER
Faculty Hospital Kralovske Vinohrady
Lead SponsorOTHER_GOV

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. expectation of permanent right ventricular pacing with atrio-ventricular delay set to 150/180 ms (130/160 resp.) for sensed/paced atrial events during a follow-up, 2. a good quality of images during echocardiography, 3. willingness to attend clinical check-ups in the implanting center for at least two years. 4. life expectancy of at least 2 years

Exclusion criteria

1. planned cardiac surgery or transcatheter aortic valve implantation 2. hypertrophic cardiomyopathy 3. an indication for implantable cardioverter-defibrillator, biventricular implantable cardioverter-defibrillator, or biventricular pacemaker 4. active myocarditis 5. cardiac surgery or coronary revascularization in the last ten days 6. persistent/permanent atrial fibrillation during randomization 7. severe aortic stenosis 8. mitral valvular disease with an indication to intervention.

Design outcomes

Primary

MeasureTime frameDescription
negative remodeling prediction1 year from randomization* 5% drop in the left ventricular ejection fraction will be predicted by the duration of UHF-ECG electrical dyssynchrony parameter * 5% drop in the left ventricular ejection fraction will be predicted by the duration of UHF-ECG left ventricular lateral wall delay parameter * 5% drop in the left ventricular ejection fraction will be predicted by the duration of UHF-ECG V6d parameter * 10% drop in the left ventricular ejection fraction will be predicted by the duration of UHF-ECG left ventricular lateral wall delay parameter * 10% drop in the left ventricular ejection fraction will be predicted by the duration of UHF-ECG V6d parameter

Secondary

MeasureTime frameDescription
RV myocardial to physiological pacing comparison2 years from randomizationleft ventricular ejection fraction comparison between low risk right ventricular myocardial to physiological pacing group
UHF-ECG prediction of clinical outcome3 years from randomizationoccurence of death, myocardial infarction, worsening heart failure or upgrade to resynchronization therapy will be predicted by the duration of UHF-ECG electrical dyssynchrony, and/or left ventricular lateral wall delay and/or V6d parameter

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026